FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner

Glioma is the most common brain tumor with a dismal prognosis. While temozolomide (TMZ) based chemotherapy significantly improves survival in glioma patients, resistance against this compound commonly leads to glioma treatment failure. Overexpression of long-noncoding RNA (LncRNA) FoxD2 adjacent opp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shangguan, Wenbing, Lv, Xuyang, Tian, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819902/
https://www.ncbi.nlm.nih.gov/pubmed/31680769
http://dx.doi.org/10.4196/kjpp.2019.23.6.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819902/
https://www.ncbi.nlm.nih.gov/pubmed/31680769
http://dx.doi.org/10.4196/kjpp.2019.23.6.475

Ejemplares similares